학술논문
Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial
Document Type
Article
Author
Romera, Alvaro; Peredpaya, Sergiy; Shparyk, Yaroslav; Bondarenko, Igor; Mendonça Bariani, Giovanni; Abdalla, Kathia Cristina; Roca, Enrique; Franke, Fábio; Melo Cruz, Felipe; Ramesh, Anita; Ostwal, Vikas; Shah, Pradeep; Rahuman, Sajeed Abdul; Paravisini, Alexandra; Huerga, Camino; Del Campo García, Ana; Millán, Susana
Source
In The Lancet Gastroenterology & Hepatology December 2018 3(12):845-855
Subject
Language
ISSN
2468-1253